IFNG and neoplasm: The findings indicated that, without impacting the IFN‐γ‐induced apoptosis of tumor cells (Figure S2A, Supporting Information), there was a significant rise in MHCI expression was observed, along with a notable reduction in PD‐L1 expression in PDOs treated with regorafenib (Figure S2B,C, Supporting Information).